NCT00398281View on ClinicalTrials.gov

Dutasteride Followed By Ultrasound-Guided Biopsy in Finding Prostate Cancer

PHASE3CompletedINTERVENTIONAL
Enrollment

450

Participants

Timeline

Start Date

November 30, 2006

Primary Completion Date

July 31, 2010

Study Completion Date

September 30, 2012

Conditions
Prostate Cancer
Interventions
DRUG

dutasteride

Given orally

OTHER

placebo

Given orally

Trial Locations (1)

19107-5541

Kimmel Cancer Center at Thomas Jefferson University - Philadelphia, Philadelphia

All Listed Sponsors
collaborator

National Cancer Institute (NCI)

NIH

lead

Sidney Kimmel Cancer Center at Thomas Jefferson University

OTHER

NCT00398281 - Dutasteride Followed By Ultrasound-Guided Biopsy in Finding Prostate Cancer | Biotech Hunter | Biotech Hunter